About Endius
Endius is a company based in Clarksville (United States) founded in 1992 was acquired by Zimmer Biomet in February 2007. Endius has raised $48.77 million across 6 funding rounds from investors including Morgan Stanley, The Carlyle Group and Zimmer Biomet. Endius operates in a competitive market with competitors including Nevro, ATEC Spine, Vertos Medical, Paradigm Spine and Relievant Medsystems, among others.
- Headquarter Clarksville, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$48.77 M (USD)
in 6 rounds
-
Latest Funding Round
$15 M (USD), Series B
May 03, 2005
-
Investors
Morgan Stanley
& 9 more
-
Employee Count
Not available
-
Acquired by
Zimmer Biomet
(Feb 09, 2007)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Endius
Endius has successfully raised a total of $48.77M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $15 million completed in May 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Endius
Endius has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Morgan Stanley, The Carlyle Group and Zimmer Biomet.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward multiple sectors.
|
Locked | Locked | Locked | |
|
US healthcare investments are managed by EGS Healthcare Capital Partners.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Endius
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Endius
Investment portfolio details for Endius
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Endius
Detailed financials for Endius
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endius Comparisons
Peer comparison for Endius
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Endius
Endius operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nevro, ATEC Spine, Vertos Medical, Paradigm Spine and Relievant Medsystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of high-frequency spinal cord stimulation implants
|
|
| Locked | Locked | Locked |
Treatment solutions for spine disorders are developed.
|
|
| Locked | Locked | Locked |
Minimally invasive treatments for lumbar spinal stenosis are developed.
|
|
| Locked | Locked | Locked |
Stabilization devices for healthcare are manufactured by the company.
|
|
| Locked | Locked | Locked |
Developer of medical devices for patients suffering from chronic vertebrogenic low back pain
|
|
| Locked | Locked | Locked |
Minimally invasive titanium implants for sacroiliac joint disorders are developed.
|
Detailed competitors of Endius
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endius
Complete news archive for Endius
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Endius
Endius was founded in 1992 and raised its 1st funding round 4 years after it was founded.
Endius is headquartered in Clarksville, United States. It is registered at Clarksville, Tennessee, United States.
Endius is a funded company, having raised a total of $48.77M across 6 funding rounds to date.
Endius was founded in 1992 and is headquartered in Clarksville, United States. Operations focus on the medical device sector, where minimally invasive tools for spine surgery are developed and supplied. These platforms support procedures such as multi-level pedicular fixation, interbody fusion, and decompression, all approached through reduced-trauma methods to address various spinal conditions.
Endius's top competitors include Nevro, Paradigm Spine and ATEC Spine.
Endius has 10 investors. Key investors include Morgan Stanley, The Carlyle Group, Zimmer Biomet, EGS Healthcare Capital Partners, and Trellis Health.